SH

Sarah Howell

Chief Executive Officer

Arecor Therapeutics plc

London, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Arecor Therapeutics plc
Industry
research
Employees
33.0
Seniority
C suite
Annual Revenue
5855000.0

Technologies

Outlook Microsoft Office 365 WP Engine Salesforce

Keywords

diabetes readytoadminister formats readytouse formats liquid products with superior stability lyotoliquid switch iv to sq high concentration mabs differentiated biosimilars vaccine stability freedomtooperate formulations biotechnology research ultra-rapid acting insulin diabetes care arestat technology therapeutic products biosimilars differentiated biopharmaceuticals subcutaneous switch injectable therapies superior peptides thermostable vaccines clinical stage development drug reformulation patient care transformation chronic conditions treatment high concentration antibodies continuous glucose monitoring automated insulin delivery biotechnology partnerships pharmaceutical collaborations enhanced formulation technologies novel therapeutic solutions medical advancements regulatory compliance product pipeline specialty pharmaceuticals injectable diabetes solutions high insulin dose convenience innovative drug development partnership licensing biopharmaceutical innovations efficacy & safety profiles reformulated medications commercial-stage products healthcare partnerships strategic collaborations seamless drug delivery systems patient-centric solutions clinical trial advancements pharmaceutical commercialization healthcare solutions market access strategies drug delivery enhancements clinical research innovations medical technology integrations improved pharmacokinetic profiles medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans